Defects in cAMP-pathway may initiate carcinogenesis in dividing nerve cells: a review

K N Prasad1, W C Cole, X-D Yan

  • 1Department of Radiology, University of Colorado Health Sciences Center, Denver, CO 80262, USA. Kedar.Prasad@UCHSC.edu

Insights

Defects in the adenosine 3

Area of Science:

  • Neuroscience
  • Cancer Biology
  • Molecular Biology

Background:

  • Carcinogenesis mechanisms in nervous tissues remain unclear.
  • Adenosine 3',5'-cyclic monophosphate (cAMP) pathway is vital for neuronal and glial cell differentiation.
  • cAMP pathway defects may initiate cancer development.

Purpose of the Study:

  • To propose a hypothesis linking cAMP pathway defects to the initial phase of carcinogenesis (immortalization).
  • To explore subsequent genetic alterations leading to neoplastic transformation.
  • To review the role of cAMP in nerve cell differentiation and carcinogenesis.

Main Methods:

  • Review of existing literature on cAMP, cell differentiation, and carcinogenesis.
  • Analysis of studies involving murine neuroblastoma (NB) cells and glioma cells.
  • Identification of potential gene targets within the cAMP pathway.

Main Results:

  • Elevated cAMP induces terminal differentiation in aneuploid NB cells.
  • cAMP-resistant cells and reversible differentiation effects are observed in NB and glioma cells.
  • Potential sites in the cAMP pathway crucial for immortalization and transformation are identified.

Conclusions:

  • cAMP pathway alterations are implicated in the initiation and progression of nervous system cancers.
  • Understanding cAMP-regulated genes is key to deciphering carcinogenesis mechanisms.
  • The cAMP pathway's role in differentiation persists despite chromosomal anomalies in cancer cells.

Related Concept Videos

Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...